(Q39406023)

11 September 2017

title

A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain (English)

1 reference

11 September 2017

0 references

Steven D Passik

1

1 reference

11 September 2017

Jeremy Lundberg

2

1 reference

11 September 2017

Kenneth L Kirsh

3

1 reference

11 September 2017

Dale Theobald

4

1 reference

11 September 2017

Kathleen Donaghy

5

1 reference

11 September 2017

Elizabeth Holtsclaw

6

1 reference

11 September 2017

Maureen Cooper

7

1 reference

11 September 2017

William Dugan

8

1 reference

11 September 2017

publication date

1 June 2002

1 reference

Journal of Pain and Symptom Management

11 September 2017

published in

1 reference

11 September 2017

volume

23

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

526-532

1 reference

Opioid-induced emesis among hospitalized nonsurgical patients: effect on pain and quality of life.

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

7 January 2021

The changeable nature of patients' fears regarding chemotherapy: implications for palliative care

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

7 January 2021

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

7 January 2021

D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

7 January 2021

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

7 January 2021

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

7 January 2021

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

7 January 2021

Reliability and applicability of movement disorder rating scales in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

7 January 2021

Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

1 reference

7 January 2021

S. P. Cotton, E. G. Levine, C. M. Fitzpatrick, K. H. Dold and E. Targ, 'Exploring the relationships among spiritual well-being, quality of life, and psychological adjustment in women with breast cancer'. psycho-oncology 8(5) 1999, 429-438

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900391-3

7 January 2021

10.1016/S0885-3924(02)00391-3

Identifiers

DOI

1 reference

11 September 2017

1 reference